Anthropometric and biochemical characteristics of the morbidly obese patients, and the obese and lean healthy subjects.

Values are presented as means ± s.d. p value represents statistical significance between the study groups determined by Kruskal-Wallis test. MO HIR/T2DM, morbidly obese patients with high insulin resistance or with type 2 diabetes mellitus; MO LIR, morbidly obese patients with low insulin resistance; BMI, body mass index; TG, triglycerides; FFA, free fatty acids; HDL-C, HDL cholesterol; LDL-C, LDL cholesterol; GOT, glutamic oxalacetic transaminase; GPT, glutamic pyruvate transaminase; GGT, γ–glutamyltransferase; HOMA-IR, Homeostasis Model Assessment of insulin resistance; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure.